Met, a receptor tyrosine kinase encoded by the proto-oncogene Met, shows dysregulated expression in numberous malignancies and is involved in cancer growth, metastasis and invasion, which make it a powerful candidate for anti-cancer therapy [84]. This evidence concerns the gene NTRK1 and cancer.